Review
References
|
Adeleye AJ, Reid G, Kao C-N, Mok-Lin E, Smith JF (2019). Semen parameters among transgender women with a history of hormonal treatment. Urology 124:136-141. |
|
|
American College of Nurse-Midwives (2019). Issues Statement Strongly Opposing Withdrawal of Gender Identity Protections in Health Care. May 29, 2019. |
|
|
Anawalt BD, Roth MY, Ceponis J (2019). Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men. Andrology 7(6):878-887. |
|
|
Angus LM, Nolan BJ, Zajac JD, Cheung AS (2021). A systematic review of antiandrogens and feminization in transgender women. Clinical Endocrinology 94(5):743-752. |
|
|
Archer DF, Mansour D, Foidart JM (2022). Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview. Journal of Clinical Medicine 11(15):4634. |
|
|
Bloom BE, Kieu TK, Wagman JA, Ulloa EC, Reed E (2022). Responsiveness of sex education to the needs of LGBTQ+ undergraduate students and its influence on sexual violence and harassment experiences. American Journal of Sexuality Education 17(3):368-399. |
|
|
Budhwani H, Turan B, Hasbun J (2017). Association between violence exposure and condom non-use among transgender sex workers in the Dominican Republic: the mediating role of trust. International Journal of STD and AIDS 28(6):608-612. |
|
|
Burgwal A, Gvianishvili N, Hård V (2019). Health disparities between binary and non-binary trans people: A community-driven survey. International Journal of Transgenderism 20(2-3):218-229. |
|
|
Butler MM, Fullerton J, Aman C (2020). Competencies for respectful maternity care: Identifying those most important to midwives worldwide. Birth 47(4):346-356. |
|
|
Cahill EP, Kaur S (2020). Advances in contraception research and development. Current Opinion in Obstetrics and Gynecology32(6):393-398. |
|
|
Cheng PJ, Pastuszak AW, Myers JB, Goodwin IA, Hotaling JM (2019). Fertility concerns of the transgender patient. Translational Andrology and Urology 8(3):209. |
|
|
Chrisler JC, Gorman JA, Manion J (2016). Queer periods: attitudes toward and experiences with menstruation in the masculine of centre and transgender community. Culture, Health and Sexuality 18(11):1238-1250. |
|
|
Cooper D, Patel P, Mahdy H (2022). Oral Contraceptive Pills. [Updated 2022 Jan 21]. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing. |
|
|
Fainberg J, Kashanian JA (2018). Vasectomy. Jama 319(23):2450-2450. |
|
|
Festin MPR (2020). Overview of modern contraception. Best Practice and Research Clinical Obstetrics and Gynaecology 66:4-14. |
|
|
Fontanari AMV, Zanella GI, Feijó M, Churchill S, Lobato MIR, Costa AB (2019). HIV-related care for transgender people: A systematic review of studies from around the world. Social Science and Medicine 230:280-294. |
|
|
Foy AA, Morris D, Fernandes V, Rimes KA (2019). LGBQ+ adults' experiences of Improving Access to Psychological Therapies and primary care counselling services: informing clinical practice and service delivery. The Cognitive Behaviour Therapist 12:e42. |
|
|
Francis A, Jasani S, Bachmann G (2018). Contraceptive challenges and the transgender individual. Women's Midlife Health 4:1-4. |
|
|
Fraser H (1993). GnRH analogues for contraception. British Medical Bulletin 49(1):62-72. |
|
|
Friedman J, Oluronbi RA (2019). Types of IUDs and mechanism of action. Optimizing IUD Delivery for Adolescents and Young Adults: Counseling, Placement, and Management pp. 29-39. |
|
|
Gava G, Cerpolini S, Martelli V, Battista G, Seracchioli R, Meriggiola MC (2016). Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness. Clinical Endocrinology 85(2):239-246. |
|
|
Gava G, Meriggiola MC (2019). Update on male hormonal contraception. Therapeutic Advances in Endocrinology and Metabolism. |
|
|
Grimes DA, Lopez LM, Raymond EG, Halpern V, Nanda K, Schulz KF (2013). Spermicide used alone for contraception. Cochrane Database of Systematic Reviews (12). |
|
|
Grimstad FW, Fowler KG, New EP (2019). Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series. American Journal of Obstetrics and Gynecology 220(3):257. e1-257. e7. |
|
|
Haider S, Darney PD (2007). Injectable contraception. Clinical Obstetrics and Gynecology 50(4):898-906. |
|
|
Haley SG, Tordoff DM, Kantor AZ, Crouch JM, Ahrens KR (2019). Sex education for transgender and non-binary youth: previous experiences and recommended content. The Journal of Sexual Medicine 16(11):1834-1848. |
|
|
Handelsman D, Waites G (2022). Male contraception. Andrology for the Clinician pp. 121-122. |
|
|
Haseen B, Kahn A, Belton A, Bayer CR (2020). Health care for transgender men: what is missing in OB/GYN care? Journal of Lower Genital Tract Disease 24(2):232-233. |
|
|
Hashemi L, Weinreb J, Weimer AK, Weiss RL (2018). Transgender care in the primary care setting: a review of guidelines and literature. Federal Practitioner 35(7):30. |
|
|
Hay K, McDougal L, Percival V (2019). Disrupting gender norms in health systems: making the case for change. The Lancet 393(10190):2535-2549. |
|
|
Hembree WC, Cohen-Kettenis PT, Gooren L (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 102(11):3869-3903. |
|
|
Hifnawy MS, Aboseada MA, Hassan HM, Tohamy AF, El Naggar EMB, Abdelmohsen UR (2021). Nature-inspired male contraceptive and spermicidal products. Phytochemistry Reviews 20:797-843. |
|
|
Kearns S, Kroll T, O'Shea D, Neff K (2021). Experiences of transgender and non-binary youth accessing gender-affirming care: A systematic review and meta-ethnography. PLoS ONE 16(9):e0257194. |
|
|
Krempasky C, Harris M, Abern L, Grimstad F (2020). Contraception across the transmasculine spectrum. American Journal of Obstetrics and Gynecology 222(2):134-143. |
|
|
Kuzma EK, Pardee M, Darling-Fisher CS (2019). Lesbian, gay, bisexual, and transgender health: Creating safe spaces and caring for patients with cultural humility. Journal of the American Association of Nurse Practitioners 31(3):167-174. |
|
|
Lapinski J, Covas T, Perkins JM (2018). Best practices in transgender health: a clinician's guide. Primary Care: Clinics in Office Practice 45(4):687-703. |
|
|
Mancini I, Alvisi S, Gava G, Seracchioli R, Meriggiola MC (2021). Contraception across transgender. International Journal of Impotence Research 33(7):710-719. |
|
|
Meerwijk EL, Sevelius JM (2017). Transgender population size in the United States: a meta-regression of population-based probability samples. American Journal of Public Health 107(2):e1-e8. |
|
|
Mehringer J, Dowshen NL (2019). Sexual and reproductive health considerations among transgender and gender-expansive youth. Current Problems in Pediatric and Adolescent Health Care 49(9):100684. |
|
|
Menning M, Schindler P (2022). Family Planning, Birth Control, and Contraception. Family Medicine: Principles and Practice. Springer, pp. 1439-1447. |
|
|
Norcross NR, Georgiou I, Johnston ZC (2022). Male contraceptive development: A medicinal chemistry perspective. European Journal of Medicinal Chemistry 243:114709. |
|
|
Obstetricians ACo, Gynecologists, Practice CoG, Obstetricians ACo, Gynecologists (2021). Women CoHCfU. Health care for transgender and gender diverse individuals: ACOG Committee Opinion, Number 823. Obstetrics and Gynecology 137(3):e75-e88. |
|
|
Paradise SL, Landis CA, Klein DA (2022). Evidence-Based Contraception: Common Questions and Answers. American Family Physician 106(3):251-259. |
|
|
Peitzmeier SM, Potter J (2017). Patients and their bodies: the physical exam. Trauma, resilience, and health promotion in LGBT patients: What Every Healthcare Provider Should Know, pp. 191-202. |
|
|
Phillips G, Davoudpour S, Floresca YB (2023). Disparities in HIV Testing, Condom Use, and HIV Education Between Transgender and Not Transgender High School-Aged Youth: Findings From the 2019 Youth Risk Behavior Survey. Health Education and Behavior 50(1):29-40. |
|
|
Phillips SP (2019). Contraception Technologies. Encyclopedia of Reproductive Technologies. Routledge, pp. 92-98. |
|
|
Rosen-Carole C, Greenberg KB (2022). Chestfeeding and lactation care for LGBTQ+ families (lesbian, gay, bisexual, transgender, queer, plus). Breastfeeding. Elsevier, pp. 646-650. |
|
|
Rubin ES, Rullo J, Tsai P (2018). Best practices in North American pre-clinical medical education in sexual history taking: consensus from the summits in medical education in sexual health. The journal of sexual medicine 15(10):1414-1425. |
|
|
Schneider F, Kliesch S, Schlatt S, Neuhaus N (2017). Andrology of male?to?female transsexuals: influence of cross?sex hormone therapy on testicular function. Andrology 5(5):873-880. |
|
|
Schulze C (1988). Response of the human testis to long-term estrogen treatment: morphology of Sertoli cells, Leydig cells and spermatogonial stem cells. Cell and Tissue Research 251:31-43. |
|
|
Schwarz E, Gariepy A, Lewis C, Borrero S, Reeves M (2017). Pregnancy after tubal sterilization in the United States, updated estimates. Contraception 96(4):268. |
|
|
Shim JY, Laufer MR, Grimstad FW (2020). Dysmenorrhea and endometriosis in transgender adolescents. Journal of Pediatric and Adolescent Gynecology 33(5):524-528. |
|
|
Siemons SE, Vleugels MP, van Balken MR, Braat DD, Nieboer TE (2022). Male or female sterilization-the decision-making process: Counselling and regret. Sexual and Reproductive Healthcare 33:100767. |
|
|
Simon L (2021). Long-Acting Reversible Contraception Education for Street-Involved Youth: Impact on Knowledge, Attitudes, and Behaviors. |
|
|
Sinha A, Mei L, Ferrando C (2021). The effect of estrogen therapy on spermatogenesis in transgender women. F&S Reports 2(3):347-351. |
|
|
Sokolakis I, Pyrgidis N, Hatzichristodoulou G (2022). Male Contraception. Andrology and Sexual Medicine. Springer pp. 271-288. |
|
|
T'Sjoen G, Radix A, Motmans J (2020). Language and ethics in transgender health. The Journal of Sexual Medicine 17(9):1585-1586. |
|
|
Tepper NK, Curtis KM, Cox S, Whiteman MK (2020). Update to US medical eligibility criteria for contraceptive use, 2016: updated recommendations for the use of contraception among women at high risk for HIV infection. Morbidity and Mortality Weekly Report 69(14):405. |
|
|
Thirumalai A, Ceponis J, Amory JK (2019). Effects of 28 days of oral dimethandrolone undecanoate in healthy men: a prototype male pill. The Journal of Clinical Endocrinology and Metabolism 104(2):423-432. |
|
|
Trussell J (2004). Contraceptive failure in the United States. Contraception 70(2):89-96. |
|
|
Trussell J, Aiken A, Micks E, Guthrie K (2018). Efficacy, safety, and personal considerations. Contraceptive Technology P 21. |
|
|
Trussell J, Strickler J, Vaughan B (1993). Contraceptive efficacy of the diaphragm, the sponge and the cervical cap. Family Planning Perspectives pp. 100-135. |
|
|
UCSF (2023). Transgender Care. |
|
|
Wu S, Yuen F, Swerdloff RS (2019). Safety and pharmacokinetics of single-dose novel oral androgen 11 β-methyl-19-nortestosterone-17 β-dodecylcarbonate in men. The Journal of Clinical Endocrinology and Metabolism 104(3):629-638. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
